Work

The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening

Year: 2019

Type: article

Source: Diabetologia

DOI: 10.1007/s00125-019-05047-w

Authors: Laura M. Jacobsen, Laura Bocchino, Carmella Evans-Molina, Linda DiMeglio, Robin Goland, Darrell M. Wilson, Mark A. Atkinson, Tandy Aye, William E. Russell, John M. Wentworth, David Boulware, Susan Geyer, Jay M. Sosenko

Institutions: University of Florida Health, University of Florida, University of South Florida, Indiana University Indianapolis, Indiana University School of Medicine, Columbia University Irving Medical Center, Columbia University, Stanford Medicine, Stanford University, Vanderbilt University Medical Center, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, University of Miami

Language: English

Topic: Diabetes and associated disorders

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Diabetes Association, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G1058663374, G1335891746, G1667355478, TrialNet: University of Florida Clinical Center and Network, G180872007, Type 1 Diabetes-A Proposal for Prevention & Intervention, CLINICAL AFFILIATE OF THE TYPE 1 DIABETES TRIALNET, G2078056140, Chicagoland Diabetes TrialNet Clinical Center, G2325591987, G2579296307, G28051265, G3345811275, Continuation of UCSF as a Clinical Center for TrialNet, G3998258134, Prediction and Prevention of Type 1 Diabetes (TrialNet), Northwest Clinical Center for Type 1 Diabetes - TrialNet, G4552347576, G457535738, G4914271708, G491993124, Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University, Type 1 Diabetes TrialNet: Toronto Clinical Center, TrialNet at Stanford University, Mechanisms of Beta Cell Function in Health and Disease, G6173851391, G66187487, G6862536402, G695377212, G701880105, TrialNet: Diabetes Type 1 Prevention, G8114795067, Texas Children's Hospital and Baylor College of Medicine TrialNet Clinical Center, Immune Function and the Progression to Type 1 Diabetes

OpenAlex ID: W2989794873

FWCI: 4.591

Cites: 35

Cited by: 133

Related to: 10